资讯
The FDA has updated its alert regarding Boston Scientific’s call for providers to check the connections of their patients’ implanted defibrillators, where calcification growth over time c | Boston ...
3 小时
Cyclingnews on MSNWaterproof fabrics jargon buster - Everything you need to know about staying dry
Not because it’s dull - although perhaps not everyone wants to hear about the best waterproof cycling jackets - but because ...
6 小时
Inquirer.net - Philippines Entertainment News on MSNAlex Gonzaga reveals undergoing nose implant removal
Alex Gonzaga revealed that she had her nose implant removed last July, a decision she made after struggling with redness and irritation on her nose for quite some time. Gonzaga opened up about having ...
09月15日,泛亚微透股价继续上涨。截至今日收盘,泛亚微透上涨2.91%,收盘价为79.34元,盘中股价最高触及80.50元,股价创历史新高。
3 天
证券之星股票频道 on MSN泛亚微透(688386)9月12日主力资金净卖出881.59万元
证券之星消息,截至2025年9月12日收盘,泛亚微透(688386)报收于77.3元,上涨5.67%,换手率2.55%,成交量2.32万手,成交额1.78亿元。
经导管瓣中瓣产品刚刚上市,商业化植入刚开始,作为独家产品,应该比经导管主动脉瓣系统有更快的覆盖。公司经导管主动脉瓣系统全年植入量目标为1000例,随着医院覆盖的增加和产品特点的体验,植入量有望持续提升;同时临床对经导管瓣中瓣的迫切需求将有力推动产品进院和上量,惠及越来越多生物瓣损毁急需治疗的患者。
The AMStent System leverages a decellularized human amniotic membrane (DCAM). New pre-clinical outcomes demonstrating ...
本报告研究2025照明EPTFE(膨体聚四氟乙稀)膜企业出海策略及业务规划,分别从生产和消费的角度分析照明EPTFE(膨体聚四氟乙稀)膜的主要生产地区、主要消费地区以及主要的生产商。重点分析全球与中国市场的主要厂商产品特点、产品规格、不同规格产品的价格 ...
The global Expanded PTFE (ePTFE) market is poised for significant growth, with projections indicating an increase from USD 838.2 million in 2024 to an impressive USD 1,490 million by 2034. This ...
本报告研究全球与中国市场ePTFE垫片的发展现状及未来发展趋势,分别从生产和消费的角度分析ePTFE垫片的主要生产地区、主要消费地区以及主要的生产商。重点分析全球与中国市场的主要厂商产品特点、产品规格、不同规格产品的价格、产量、产值及全球和中国 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果